Funded Grants

CHCHD10 is a nuclear encoded mitochondrial protein of the twin Cx9C family whose cellular function remains to be fully understood.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, primarily affecting motor neurons, for which there are currently no adequately effective therapies.

In Canada, 1 in 20 people live with depression. Substantial efforts have been made over the years to develop new treatments to enhance therapeutic options.

The brain is more than the sum of its parts.

Spinal cord injury (SCI) is a devastating medical condition that forever changes the trajectory of life.

Depression will affect 1 out of 5 individuals in their lifetime.

Late-onset Alzheimer’s (late-AD) is a complex neurodegenerative condition with abnormalities in toxic protein accumulation, vascularization, inflammation, neuronal activity and cerebral atrophy.

Canada recently became the first G7 nation to legalize Cannabis for medicinal and recreational use.

The MHCC, in collaboration with CSA Group (as the standards development organization), has championed the development of the CSA Z2003 Mental health and well-being for post-secondary students standard.